Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value
$196.99M
Total Bought
$4.33M
Total Sold
$18.05M
Net Transaction
-$13.72M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG ONCOLOGY INC(CGON)1,131,5011,131,501029,41945,57723.14%+16,158
TREVI THERAPEUTICS INC(TRVI)2,144,8442,144,844011,73219,6259.96%+7,893
UROGEN PHARMA LTD(URGN)1,259,7491,259,749017,25925,13212.76%+7,873
PUMA BIOTECHNOLOGY INC(PBYI)4,131,2994,131,299014,17021,93711.14%+7,767
TERNS PHARMACEUTICALS INC1,971,2641,971,26407,35314,8047.52%+7,451
BICARA THERAPEUTICS643,382643,38205,97710,1595.16%+4,182
VERASTEM INC(VSTM)779,498779,49803,2356,8833.49%+3,648
JASPER THERAPEUTICS(JSPR)01,382,640+1,382,64003,2911.67%+3,291
PROTARA THERAPEUTICS INC(TARA)1,752,1151,752,11505,3097,6223.87%+2,313
BIOATLA INC(BCAB)4,835,1114,835,11101,9153,3361.69%+1,422
ONKURE THERAPEUTICS INC(OKUR)2,839,6742,839,67406,7877,8093.96%+1,022
X4 PHARMACEUTICALS INC(XFOR)153,730273,349+119,6192929350.47%+643
Q32 BIO INC.(FIXX)803,425803,42501,1971,5910.81%+394
ACRIVON THERAPEUTICS INC405,237405,23704827330.37%+251
CANDEL THERAPEUTICS INC(CADL)2,580,5172,580,517013,05713,1616.68%+103
WHITEHAWK THERAPEUTICS INC(WHWK)1,139,3631,139,36302,1312,1651.10%+34
AURA BIOSCIENCES INC(AURA)595,744595,74403,7293,6821.87%-48
CARDIF ONCOLOGY INC(CRDF)1,408,7671,962,084+553,3174,4384,0422.05%-396
VYNE THERAPEUTICS INC(YARW)736,572586,572-150,0001,2151990.10%-1,016
MURAL ONCOLOGY PLC653,7790-653,7791,6150—-1,615
CYBIN INC(HELP)734,394734,39406,1624,3112.19%-1,851
Y-MABS THERAPEUTICS INC3,418,9950-3,418,99515,4200—-15,420
Page 1 of 1
ACORN CAPITAL ADVISORS, LLC — 13F Holdings — Q3 2025 | TickerTrail